Preclinical Safety Evaluation of a Recombinant AAV8 Vector for X-Linked Retinoschisis After Intravitreal Administration in Rabbits

Human gene therapy. Clinical development - United States
doi 10.1089/humc.2014.067
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Ocular and Systemic Safety of a Recombinant AAV8 Vector for X-Linked Retinoschisis Gene Therapy: GLP Studies in Rabbits and Rs1-Ko Mice

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2016English

Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine Hydrolase Gene Therapy: A Good Laboratory Practice Preclinical Study in Mice

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2020English

Retinal Function in X-Linked Juvenile Retinoschisis

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

X-Linked Retinoschisis: Phenotypic Variability in a Chinese Family

Scientific Reports
Multidisciplinary
2016English

Refractory Macular Edema in X-Linked Juvenile Retinoschisis

Ophthalmology Journal
2019English

402. Gait Function in a Canine Model of X-Linked Myotubular Myopathy After Systemic Delivery of AAV8-MTM1

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Bullous X Linked Retinoschisis: Clinical Features and Prognosis

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Optical Coherence Tomographic Findings in X-Linked Juvenile Retinoschisis

Archives of Ophthalmology
2005English

Multimodal Imaging in a Pedigree of X-Linked Retinoschisis With a Novel RS1 Variant

BMC Medical Genetics
Genetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy